Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Difficult to control atopic dermatitis.
Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis / EADV Eczema Task Force. Darsow U, et al. Among authors: lubbe j. World Allergy Organ J. 2013 Mar 14;6(1):6. doi: 10.1186/1939-4551-6-6. World Allergy Organ J. 2013. PMID: 23663504 Free PMC article.
Position paper on diagnosis and treatment of atopic dermatitis.
Darsow U, Lübbe J, Taïeb A, Seidenari S, Wollenberg A, Calza AM, Giusti F, Ring J; European Task Force on Atopic Dermatitis. Darsow U, et al. Among authors: lubbe j. J Eur Acad Dermatol Venereol. 2005 May;19(3):286-95. doi: 10.1111/j.1468-3083.2005.01249.x. J Eur Acad Dermatol Venereol. 2005. PMID: 15857453
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis.
Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis/EADV Eczema Task Force. Darsow U, et al. Among authors: lubbe j. J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28. doi: 10.1111/j.1468-3083.2009.03415.x. Epub 2009 Aug 31. J Eur Acad Dermatol Venereol. 2010. PMID: 19732254 Review.
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort.
Simon D, Lübbe J, Wüthrich B, Wiesner A, Weber MM, Laffitte E, Anliker MD, Schöni MH, Braathen LR, Schmid-Grendelmeier P, Gilgen Bobalj N, Schneider D. Simon D, et al. Among authors: lubbe j. Dermatology. 2006;213(4):313-8. doi: 10.1159/000096195. Dermatology. 2006. PMID: 17135737 Free article. Clinical Trial.
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.
Lübbe J, Friedlander SF, Cribier B, Morren MA, García-Díez A, Gelmetti C, Hofmann H, Houwing RH, Kownacki S, Langley RG, Virtanen M, Wolff K, Wisseh S, McGeown C, Abrams B, Schneider D; NOBEL (New Online Based ELidel) Study Group. Lübbe J, et al. Am J Clin Dermatol. 2006;7(2):121-31. doi: 10.2165/00128071-200607020-00005. Am J Clin Dermatol. 2006. PMID: 16605292 Clinical Trial.
132 results